Global Leukemia Targeted Therapy Drugs Market Research Report 2026

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukemia Targeted Therapy Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Monoclonal Antibodies
1.2.3 Small-Molecule Drugs
1.3 Market by Application
1.3.1 Global Leukemia Targeted Therapy Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Acute Myeloid Leukemia (AML)
1.3.3 Chronic Myeloid Leukemia (CML)
1.3.4 Acute Lymphoblastic Leukemia (ALL)
1.3.5 Chronic Lymphocytic Leukemia (CLL)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Leukemia Targeted Therapy Drugs Market Perspective (2021–2032)
2.2 Global Leukemia Targeted Therapy Drugs Growth Trends by Region
2.2.1 Global Leukemia Targeted Therapy Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Leukemia Targeted Therapy Drugs Historic Market Size by Region (2021–2026)
2.2.3 Leukemia Targeted Therapy Drugs Forecasted Market Size by Region (2027–2032)
2.3 Leukemia Targeted Therapy Drugs Market Dynamics
2.3.1 Leukemia Targeted Therapy Drugs Industry Trends
2.3.2 Leukemia Targeted Therapy Drugs Market Drivers
2.3.3 Leukemia Targeted Therapy Drugs Market Challenges
2.3.4 Leukemia Targeted Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leukemia Targeted Therapy Drugs Players by Revenue
3.1.1 Global Top Leukemia Targeted Therapy Drugs Players by Revenue (2021–2026)
3.1.2 Global Leukemia Targeted Therapy Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top Leukemia Targeted Therapy Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Leukemia Targeted Therapy Drugs Revenue
3.4 Global Leukemia Targeted Therapy Drugs Market Concentration Ratio
3.4.1 Global Leukemia Targeted Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukemia Targeted Therapy Drugs Revenue in 2025
3.5 Global Key Players of Leukemia Targeted Therapy Drugs Head Offices and Areas Served
3.6 Global Key Players of Leukemia Targeted Therapy Drugs, Products and Applications
3.7 Global Key Players of Leukemia Targeted Therapy Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Leukemia Targeted Therapy Drugs Breakdown Data by Type
4.1 Global Leukemia Targeted Therapy Drugs Historic Market Size by Type (2021–2026)
4.2 Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Type (2027–2032)
5 Leukemia Targeted Therapy Drugs Breakdown Data by Application
5.1 Global Leukemia Targeted Therapy Drugs Historic Market Size by Application (2021–2026)
5.2 Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Leukemia Targeted Therapy Drugs Market Size (2021–2032)
6.2 North America Leukemia Targeted Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Leukemia Targeted Therapy Drugs Market Size by Country (2021–2026)
6.4 North America Leukemia Targeted Therapy Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Leukemia Targeted Therapy Drugs Market Size (2021–2032)
7.2 Europe Leukemia Targeted Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Leukemia Targeted Therapy Drugs Market Size by Country (2021–2026)
7.4 Europe Leukemia Targeted Therapy Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Leukemia Targeted Therapy Drugs Market Size (2021–2032)
8.2 Asia-Pacific Leukemia Targeted Therapy Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Leukemia Targeted Therapy Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific Leukemia Targeted Therapy Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Leukemia Targeted Therapy Drugs Market Size (2021–2032)
9.2 Latin America Leukemia Targeted Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Leukemia Targeted Therapy Drugs Market Size by Country (2021–2026)
9.4 Latin America Leukemia Targeted Therapy Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leukemia Targeted Therapy Drugs Market Size (2021–2032)
10.2 Middle East & Africa Leukemia Targeted Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Leukemia Targeted Therapy Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa Leukemia Targeted Therapy Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis Pharms
11.1.1 Novartis Pharms Company Details
11.1.2 Novartis Pharms Business Overview
11.1.3 Novartis Pharms Leukemia Targeted Therapy Drugs Introduction
11.1.4 Novartis Pharms Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.1.5 Novartis Pharms Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Leukemia Targeted Therapy Drugs Introduction
11.2.4 Bristol-Myers Squibb Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 IL-Yang Pharms
11.3.1 IL-Yang Pharms Company Details
11.3.2 IL-Yang Pharms Business Overview
11.3.3 IL-Yang Pharms Leukemia Targeted Therapy Drugs Introduction
11.3.4 IL-Yang Pharms Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.3.5 IL-Yang Pharms Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Leukemia Targeted Therapy Drugs Introduction
11.4.4 Pfizer Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.4.5 Pfizer Recent Development
11.5 Takeda Oncology
11.5.1 Takeda Oncology Company Details
11.5.2 Takeda Oncology Business Overview
11.5.3 Takeda Oncology Leukemia Targeted Therapy Drugs Introduction
11.5.4 Takeda Oncology Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.5.5 Takeda Oncology Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Leukemia Targeted Therapy Drugs Introduction
11.6.4 Johnson & Johnson Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.6.5 Johnson & Johnson Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Details
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Leukemia Targeted Therapy Drugs Introduction
11.7.4 Gilead Sciences Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.7.5 Gilead Sciences Recent Development
11.8 Abbvie
11.8.1 Abbvie Company Details
11.8.2 Abbvie Business Overview
11.8.3 Abbvie Leukemia Targeted Therapy Drugs Introduction
11.8.4 Abbvie Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.8.5 Abbvie Recent Development
11.9 Genentech
11.9.1 Genentech Company Details
11.9.2 Genentech Business Overview
11.9.3 Genentech Leukemia Targeted Therapy Drugs Introduction
11.9.4 Genentech Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.9.5 Genentech Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Leukemia Targeted Therapy Drugs Introduction
11.10.4 Sanofi Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.10.5 Sanofi Recent Development
11.11 Amgen
11.11.1 Amgen Company Details
11.11.2 Amgen Business Overview
11.11.3 Amgen Leukemia Targeted Therapy Drugs Introduction
11.11.4 Amgen Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.11.5 Amgen Recent Development
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche Leukemia Targeted Therapy Drugs Introduction
11.12.4 Roche Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.12.5 Roche Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Details
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Leukemia Targeted Therapy Drugs Introduction
11.13.4 GlaxoSmithKline Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.13.5 GlaxoSmithKline Recent Development
11.14 AstraZeneca
11.14.1 AstraZeneca Company Details
11.14.2 AstraZeneca Business Overview
11.14.3 AstraZeneca Leukemia Targeted Therapy Drugs Introduction
11.14.4 AstraZeneca Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.14.5 AstraZeneca Recent Development
11.15 BeiGene
11.15.1 BeiGene Company Details
11.15.2 BeiGene Business Overview
11.15.3 BeiGene Leukemia Targeted Therapy Drugs Introduction
11.15.4 BeiGene Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.15.5 BeiGene Recent Development
11.16 Eli Lilly
11.16.1 Eli Lilly Company Details
11.16.2 Eli Lilly Business Overview
11.16.3 Eli Lilly Leukemia Targeted Therapy Drugs Introduction
11.16.4 Eli Lilly Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.16.5 Eli Lilly Recent Development
11.17 Merck
11.17.1 Merck Company Details
11.17.2 Merck Business Overview
11.17.3 Merck Leukemia Targeted Therapy Drugs Introduction
11.17.4 Merck Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.17.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Leukemia Targeted Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Small-Molecule Drugs
Table 4. Global Leukemia Targeted Therapy Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Leukemia Targeted Therapy Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Leukemia Targeted Therapy Drugs Market Size by Region (US$ Million), 2021–2026
Table 7. Global Leukemia Targeted Therapy Drugs Market Share by Region (2021–2026)
Table 8. Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Leukemia Targeted Therapy Drugs Market Share by Region (2027–2032)
Table 10. Leukemia Targeted Therapy Drugs Market Trends
Table 11. Leukemia Targeted Therapy Drugs Market Drivers
Table 12. Leukemia Targeted Therapy Drugs Market Challenges
Table 13. Leukemia Targeted Therapy Drugs Market Restraints
Table 14. Global Leukemia Targeted Therapy Drugs Revenue by Players (US$ Million), 2021–2026
Table 15. Global Leukemia Targeted Therapy Drugs Market Share by Players (2021–2026)
Table 16. Global Top Leukemia Targeted Therapy Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Leukemia Targeted Therapy Drugs Revenue, 2025
Table 17. Ranking of Global Top Leukemia Targeted Therapy Drugs Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Leukemia Targeted Therapy Drugs Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Leukemia Targeted Therapy Drugs, Headquarters and Area Served
Table 20. Global Key Players of Leukemia Targeted Therapy Drugs, Products and Applications
Table 21. Global Key Players of Leukemia Targeted Therapy Drugs, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Leukemia Targeted Therapy Drugs Market Size by Type (US$ Million), 2021–2026
Table 24. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Type (2021–2026)
Table 25. Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Type (2027–2032)
Table 27. Global Leukemia Targeted Therapy Drugs Market Size by Application (US$ Million), 2021–2026
Table 28. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Application (2021–2026)
Table 29. Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Application (2027–2032)
Table 31. North America Leukemia Targeted Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2021–2026
Table 33. North America Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Leukemia Targeted Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Leukemia Targeted Therapy Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Leukemia Targeted Therapy Drugs Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Leukemia Targeted Therapy Drugs Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Leukemia Targeted Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Leukemia Targeted Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2027–2032
Table 46. Novartis Pharms Company Details
Table 47. Novartis Pharms Business Overview
Table 48. Novartis Pharms Leukemia Targeted Therapy Drugs Product
Table 49. Novartis Pharms Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 50. Novartis Pharms Recent Development
Table 51. Bristol-Myers Squibb Company Details
Table 52. Bristol-Myers Squibb Business Overview
Table 53. Bristol-Myers Squibb Leukemia Targeted Therapy Drugs Product
Table 54. Bristol-Myers Squibb Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 55. Bristol-Myers Squibb Recent Development
Table 56. IL-Yang Pharms Company Details
Table 57. IL-Yang Pharms Business Overview
Table 58. IL-Yang Pharms Leukemia Targeted Therapy Drugs Product
Table 59. IL-Yang Pharms Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 60. IL-Yang Pharms Recent Development
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Leukemia Targeted Therapy Drugs Product
Table 64. Pfizer Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 65. Pfizer Recent Development
Table 66. Takeda Oncology Company Details
Table 67. Takeda Oncology Business Overview
Table 68. Takeda Oncology Leukemia Targeted Therapy Drugs Product
Table 69. Takeda Oncology Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 70. Takeda Oncology Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Leukemia Targeted Therapy Drugs Product
Table 74. Johnson & Johnson Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 75. Johnson & Johnson Recent Development
Table 76. Gilead Sciences Company Details
Table 77. Gilead Sciences Business Overview
Table 78. Gilead Sciences Leukemia Targeted Therapy Drugs Product
Table 79. Gilead Sciences Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 80. Gilead Sciences Recent Development
Table 81. Abbvie Company Details
Table 82. Abbvie Business Overview
Table 83. Abbvie Leukemia Targeted Therapy Drugs Product
Table 84. Abbvie Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 85. Abbvie Recent Development
Table 86. Genentech Company Details
Table 87. Genentech Business Overview
Table 88. Genentech Leukemia Targeted Therapy Drugs Product
Table 89. Genentech Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 90. Genentech Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Leukemia Targeted Therapy Drugs Product
Table 94. Sanofi Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 95. Sanofi Recent Development
Table 96. Amgen Company Details
Table 97. Amgen Business Overview
Table 98. Amgen Leukemia Targeted Therapy Drugs Product
Table 99. Amgen Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 100. Amgen Recent Development
Table 101. Roche Company Details
Table 102. Roche Business Overview
Table 103. Roche Leukemia Targeted Therapy Drugs Product
Table 104. Roche Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 105. Roche Recent Development
Table 106. GlaxoSmithKline Company Details
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Leukemia Targeted Therapy Drugs Product
Table 109. GlaxoSmithKline Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 110. GlaxoSmithKline Recent Development
Table 111. AstraZeneca Company Details
Table 112. AstraZeneca Business Overview
Table 113. AstraZeneca Leukemia Targeted Therapy Drugs Product
Table 114. AstraZeneca Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 115. AstraZeneca Recent Development
Table 116. BeiGene Company Details
Table 117. BeiGene Business Overview
Table 118. BeiGene Leukemia Targeted Therapy Drugs Product
Table 119. BeiGene Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 120. BeiGene Recent Development
Table 121. Eli Lilly Company Details
Table 122. Eli Lilly Business Overview
Table 123. Eli Lilly Leukemia Targeted Therapy Drugs Product
Table 124. Eli Lilly Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 125. Eli Lilly Recent Development
Table 126. Merck Company Details
Table 127. Merck Business Overview
Table 128. Merck Leukemia Targeted Therapy Drugs Product
Table 129. Merck Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
Table 130. Merck Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report


List of Figures
Figure 1. Leukemia Targeted Therapy Drugs Picture
Figure 2. Global Leukemia Targeted Therapy Drugs Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Leukemia Targeted Therapy Drugs Market Share by Type: 2025 vs 2032
Figure 4. Monoclonal Antibodies Features
Figure 5. Small-Molecule Drugs Features
Figure 6. Global Leukemia Targeted Therapy Drugs Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Leukemia Targeted Therapy Drugs Market Share by Application: 2025 vs 2032
Figure 8. Acute Myeloid Leukemia (AML) Case Studies
Figure 9. Chronic Myeloid Leukemia (CML) Case Studies
Figure 10. Acute Lymphoblastic Leukemia (ALL) Case Studies
Figure 11. Chronic Lymphocytic Leukemia (CLL) Case Studies
Figure 12. Leukemia Targeted Therapy Drugs Report Years Considered
Figure 13. Global Leukemia Targeted Therapy Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Leukemia Targeted Therapy Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Leukemia Targeted Therapy Drugs Market Share by Region: 2025 vs 2032
Figure 16. Global Leukemia Targeted Therapy Drugs Market Share by Players in 2025
Figure 17. Global Leukemia Targeted Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Leukemia Targeted Therapy Drugs Revenue in 2025
Figure 19. North America Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Leukemia Targeted Therapy Drugs Market Share by Country (2021–2032)
Figure 21. United States Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Leukemia Targeted Therapy Drugs Market Share by Country (2021–2032)
Figure 25. Germany Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Leukemia Targeted Therapy Drugs Market Share by Region (2021–2032)
Figure 33. China Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Leukemia Targeted Therapy Drugs Market Share by Country (2021–2032)
Figure 41. Mexico Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Leukemia Targeted Therapy Drugs Market Share by Country (2021–2032)
Figure 45. Israel Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Novartis Pharms Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 50. IL-Yang Pharms Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 51. Pfizer Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 52. Takeda Oncology Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 53. Johnson & Johnson Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 54. Gilead Sciences Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 55. Abbvie Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 56. Genentech Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 57. Sanofi Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 58. Amgen Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 59. Roche Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 61. AstraZeneca Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 62. BeiGene Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 63. Eli Lilly Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 64. Merck Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit